BIOS Capital Management, LP

CIK 0001813845 · FORT WORTH, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗

BIOS Capital Management, LP reported 6 positions worth $41.7M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: ACTU (36.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.

$41.7M

2026 Q2

Positions

Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.

100.0%

Est. Net Flow (Q)

—

2026 Q2

Positions Changes Mix History BacktestPRO

6 positions shown

#	Symbol	Company	Type	Value ↓	% Port.	Shares	1Y	YTD
▸ 1	ACTU	ACTUATE THERAPEUTICS INC	SH	$15.4M	36.90%	10,049,996	—	—
▸ 2	IRD	OPUS GENETICS INC	SH	$15.1M	36.33%	3,683,429	—	—
▸ 3	CGTX	COGNITION THERAPEUTICS INC	SH	$6.9M	16.56%	6,000,000	—	—
▸ 4	RNTX	REIN THERAPEUTICS INC	SH	$3.1M	7.44%	2,982,375	—	—
▸ 5	LTRN	LANTERN PHARMA INC	SH	$1.0M	2.50%	249,397	—	—
▸ 6	INAB	IN8BIO INC	SH	$114.1K	0.27%	80,957	—	—

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does BIOS Capital Management, LP hold as of Q2 2026?

BIOS Capital Management, LP reported 6 positions worth $41.7M in its Q2 2026 13F filing. Largest positions: ACTU (36.9%), IRD (36.3%), CGTX (16.6%), RNTX (7.4%) and LTRN (2.5%).

What did BIOS Capital Management, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did BIOS Capital Management, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.